Liver Cirrhosis: all 1,668 studies
Page 9 of 17. Open to participants first (360), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.Status unknownNCT04679571Not applicable
- Liquid Biopsy for NASH and Liver FibrosisCompletedNCT04677101
- Bariatric Endoscopy and NAFLDStatus unknownNCT04669470Not applicable
- Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient MeasurementsCompletedNCT04668664
- HepQuant to Predict Hepatic Encephalopathy After TIPSWithdrawnNCT04664621Not applicable
- EUS Share-wave in Patients With Liver CirrhosisCompletedNCT04644055
- Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses of MGL-3196 in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Control SubjectsCompletedNCT04643795Phase 1
- Defining the Mechanisms Underlying Adrenal Insufficiency in CirrhosisCompletedNCT04642391
- Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastographyStatus unknownNCT04640350
- TIPS Combined With Microwave Ablation in HCC Patients With Refractory AscitesStatus unknownNCT04640116Not applicable
- Endoscopic Ruler for the Assessment of Variceal Bleeding Risks (CHESS2005)Status unknownNCT04639323
- Physical Therapy for Liver CirrhosisCompletedNCT04629456Not applicable
- Quantitative MRI Imaging in Diffuse Liver DiseasesStatus unknownNCT04626492
- Role of Fecal Microbiota in Predicting Graft Rejection and Sepsis Among Recipients of Living Donor Liver Transplant in First Year.Status unknownNCT04621812
- Volatile Organic Compounds for the Assessment of Liver DiseaseCompletedNCT04620538
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver FibrosisWithdrawnNCT04607655Phase 1/2
- Clinical Application of Fibroblast Activation Protein PET/MRI in Liver FibrosisStatus unknownNCT04605939Not applicable
- Use of EL-FIT App to Promote Physical ActivityCompletedNCT04604860Not applicable
- Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 DiabetesActive, not recruitingNCT04595474
- Angiotensin 2 for AKI After OLTActive, not recruitingNCT04592744Phase 4
- Fecal Microbiota Transplantation in CirrhosisStatus unknownNCT04591522Not applicable
- Magnetic-assisted Capsule Endoscope With 3D Images in EV Detection in Cirrhotic PatientStatus unknownNCT04588974
- Clinical Trials to Compare the Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Significant Hepatic Fibrosis With Type 2 DiabetesStatus unknownNCT04584242Phase 4
- Clinical Performance of LIVERFASt Test Compared w/ Liver Biopsy in Patients w/ NAFLD.CompletedNCT04579874Not applicable
- Comparison of Criteria for Liver Transplantation in Hepatocellular CarcinomaCompletedNCT04576572
- The Role of Immune Semaphorins in NAFLDCompletedNCT04573543
- NAFLD and Liver Fibrosis in Obese AdolescentsCompletedNCT04561804
- A Study of EDP-297 in Healthy SubjectsCompletedNCT04559126Phase 1
- Cognitive Function of Alcoholic Compensated Liver CirrhosisCompletedNCT04557774
- Ultrasound-guided Ipsilateral Transverse Abdominis Plane and Ilioinguinal Iliohypogastric Nerve Block.CompletedNCT04553328Not applicable
- Endoscopic and Microbiological Assessment of the Effect of Carvedilol Combined With Berberine on GOV in CirrhosisStatus unknownNCT04543643Phase 3
- Endosonographic Shear Wave Elastography for Liver StiffnessStatus unknownNCT04533932
- 68Ga-FAPI PET/CT in Liver Fibrosis PatientsStatus unknownNCT04533828Early Phase 1
- Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary AtresiaCompletedNCT04522869Phase 1/2
- Sustained Low Efficiency Dialysis Versus Continuous Renal Replacement Therapy for Acute Kidney Injury in Critically Ill CirrhoticsCompletedNCT04494542Not applicable
- Efficacy of Vitamin C on AKI Outcomes in Critically Ill Cirrhotics With Multidrug-resistant Bacterial Infections.CompletedNCT04494451Not applicable
- Liver Fibrosis and Gut Microbiota in Patients With Psoriasis Vulgaris and Rheumatoid Arthritis on MethotrexateStatus unknownNCT04493762
- Shear Wave ElastographyCompletedNCT04493346
- Tranexamic Acid for Acute Upper Gastrointestinal Bleed in CirrhosisStatus unknownNCT04489108Not applicable
- Malnutrition in Chronic Gastrointestinal Diseases, Cross-sectional StudyCompletedNCT04474743
- The Relationship Betweensarcopenia And Myosteatosis With The Natural History Of Liver CirrhosisStatus unknownNCT04466709
- Organ Dysfunction Associated With Intra Abdominal Pressures in Liver TransplantationStatus unknownNCT04463745
- Rotational Thromboelastometry Guided Blood Component Use in Children With Cirrhosis Undergoing Invasive Procedures: A Randomized Controlled TrialCompletedNCT04460222Not applicable
- To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.Status unknownNCT04443049Not applicable
- To Study Efficacy of Albumin in Cirrhosis With Spontaneous Bacterial Peritonitis at Low Risk for AKI DevelopmentStatus unknownNCT04437810Not applicable
- Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein ThrombosisStatus unknownNCT04433481Not applicable
- Prospective Cohort Study of Disease and Outcomes in CirrhosisStatus unknownNCT04422223
- Safety and Efficacy of Small Frequent Paracentesis Using an Indwelling CAtheter Compared With Repeated Large Volume Paracentesis in Cirrhotic Patients With REfractory AscitesStatus unknownNCT04406298Not applicable
- Oral Health Status in Patients With Cirrhosis and Effect of Dental Treatment on MELD Score of Cirrhosis PatientsStatus unknownNCT04399512Not applicable
- Anticoagulation Therapy After Splenectomy in Cirrhosis PatientCompletedNCT04397289Phase 1/2
- Effect of Naltrexone in Achieving and Maintaining Abstinence From Alcohol in Patients With Cirrhosis.CompletedNCT04391764Not applicable
- Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As ReferenceCompletedNCT04389593
- Efficacy of Narrow Band Spectrum Endoscopy for the Diagnosis of Gastric Antral Vascular Ectasia in Patients With Liver CirrhosisCompletedNCT04388150
- Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH CirrhosisActive, not recruitingNCT04383951Not applicable
- The Use of the Transient Elastography Paediatric Probe, Compared to the M Probe, Indirect Biomarkers and HistologyCompletedNCT04380493
- Terlipression Prevent Developing of Acute Kidney Injury During Upper-gastroentestinal BleedingCompletedNCT04358016Phase 4
- Hemodynamic Profile of Terlipressin and Octreotide in Patients With Cirrhosis and Portal Hypertension. A Randomised, Single Blinded Clinical Trial.Status unknownNCT04353193Phase 4
- Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver CirrhosisCompletedNCT04352309
- The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver.Status unknownNCT04345640
- Electrophysiological Evaluation of Motor Dysfunction in Liver Cirrhotic PatientsCompletedNCT04340999
- Global Coagulation Assessment in Cirrhosis and ACLFCompletedNCT04332484
- Periodontal Therapy and Oral-gut-hepatic Axis Cirrhosis: a Randomized Controlled TrialStatus unknownNCT04330469Not applicable
- COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational StudyCompletedNCT04329559
- International Alfapump Cohort StudyActive, not recruitingNCT04326946
- The Utility of Breath Biopsy as a Screening Tool for HCCCompletedNCT04326491
- Continuous Passive Paracentesis for Intra-abdominal HypertensionStatus unknownNCT04322201Not applicable
- Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.TerminatedNCT04311489Phase 2
- A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)Status unknownNCT04278820Phase 2
- The Use of Novel Diagnostic Tools to Increase Detection of Early Fibrosis in Cystic Fibrosis Related Liver Disease to Improve Clinical ManagementCompletedNCT04277819
- RAI & HRS: Relationship Between Relative Adrenal Insufficiency and Failure of Treatment in Hepatorenal SyndromeCompletedNCT04273750
- ADAMTS-13 and Von Willebrand Factor Levels and Activities in Children With Cirrhosis and/or Portal HypertensionCompletedNCT04267406
- Assessment of Hemostatic Profile in Liver CirrhosisCompletedNCT04265508
- HVPG-Guided Therapy vs Carvedilol Plus Endotherapy for the Prevention of Esophageal Variceal Rebleeding in Cirrhotic PatientsStatus unknownNCT04254822Not applicable
- Graft Inflow Modulation for Portal Hyper-perfusion in Live Donor Liver TransplantationCompletedNCT04252794Not applicable
- EUS Based Prevalence of Chronic Pancreatitis in Alcoholic CirrhosisStatus unknownNCT04245189
- Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal DysmotilityWithdrawnNCT04244877Phase 3
- Combination of Autologous MSC and HSC Infusion in Patients With Decompensated CirrhosisCompletedNCT04243681Phase 4
- Frailty in Patients With Cirrhosis: Prognostic Value of the Phase Angle in Hospitalized Patients and Effect of Multifactorial InterventionCompletedNCT04243148Not applicable
- Assessing of Physicians' Knowledge About International Guidelines of Albumin Use in Patients With Liver CirrhosisStatus unknownNCT04242979Not applicable
- Risk Assessment After Acute Upper Gastrointestinal Haemorrhage in CirrhosisStatus unknownNCT04235166
- Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCCStatus unknownNCT04221347
- Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCCCompletedNCT04212286Not applicable
- Diagnostic Efficacies of Sonazoid-CEUS and EOB-MRI in Patients With High Risk of HCCStatus unknownNCT04212273Not applicable
- TIPS vs. NSBB Plus Endotherapy for the Prevention of Variceal Rebleeding in NSBB Non-responders of Primary ProphylaxisStatus unknownNCT04207398Not applicable
- 4beta-hydroxycholesterol in CirrhosisSuspendedNCT04199910
- Interventional Devascularization Plus HVPG-Guided Carvedilol Therapy vs TIPSStatus unknownNCT04198259Not applicable
- Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Hepatitis b Virus Related Compensated CirrhosisStatus unknownNCT04196998Not applicable
- Dual Arterial Phase Liver CT in Patients With Suspected Portal HypertensionStatus unknownNCT04195971Not applicable
- Microbiome Translocation in Different Circulatory Compartments in Decompensated CirrhosisStatus unknownNCT04195724Not applicable
- EGD vs EUS in Diagnosing Portal Hypertension in Cirrhotic Patients.Status unknownNCT04191369Not applicable
- Optimal Clinical Predictors to AKI in Cirrhotic Patients Experienced Acute Gastrointestinal HemorrhageStatus unknownNCT04184934
- Chemotherapy and Liver Cirrhosis in Frequently-associated CancersTerminatedNCT04179773
- ELRIAH Score: A Simple Score for HCC Risk Stratification in CHC Patients With Cirrhosis or Advanced Liver Fibrosis Who Achieved SVR Following DAA TherapyCompletedNCT04173520
- MTX-related Liver Toxicity in Psoriasis Patients, Using Ultrasound-based Techniques as a Diagnostic ToolStatus unknownNCT04168619
- Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated CirrhosisStatus unknownNCT04160897
- Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care UnitTerminatedNCT04160039Not applicable
- Nurse Assisted Post-discharge Intervention in Decompensated CirrhosisCompletedNCT04158986Not applicable
- EUS Elastography for Predicting Cirrhotic-related ComplicationsActive, not recruitingNCT04155398
- Investigational Microbiota Restoration Therapeutic for Hepatic EncephalopathyTerminatedNCT04155099Phase 2
- Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients (IMPROVE Study)CompletedNCT04146636Not applicable